After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Vertex Pharmaceuticals, Inc is $114.05B. A total of 1.35 million shares were traded on the day, compared to an average of 1.49M shares.
In the most recent transaction, WAGNER CHARLES F JR sold 14,000 shares of VRTX for 456.00 per share on Dec 03 ’25. After the transaction, the EVP, CO & FO now owns 37,725 company shares. In a previous transaction on Dec 03 ’25, Tatsis Ourania sold 4,500 shares at 449.99 per share. VRTX shares that EVP, Chief Reg. & Quality Off. owns now total 46,793.
Among the insiders who sold shares, LEIDEN JEFFREY M disposed of 63,781 shares on Dec 03 ’25 at a per-share price of $449.20. This resulted in the Executive Chairman holding 24,026 shares of VRTX after the transaction. In another insider transaction, Biller Jonathan sold 347 shares at $449.00 per share on Dec 03 ’25. Company shares held by the EVP and Chief Legal Officer now total 15,306.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VRTX has a high of $519.68 and a low of $362.50.
As of this writing, VRTX has an earnings estimate of $5.19 per share for the current quarter. EPS was calculated based on a consensus of 22.0 estimates, with a high estimate of $5.78 per share and a lower estimate of $4.46. The company reported an EPS of $3.98 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $68.20, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.12.
